You are here

Article Text

Article menu
Download PDFPDF
NICE Guidelines: commentaries
The National Chlamydia Screening Programme and the NICE guidance on one-to-one interventions: remember the under-25s
  1. Ian Simms1,
  2. Teresa Battison1,
  3. Mary Macintosh1,
  4. Sarah Randall1,
  5. Jan Clarke2
  1. 1National Chlamydia Screening Programme, HIV & STI Department, Health Protection Agency Centre for Infections, London, UK
  2. 2Chair, National Chlamydia Screening Steering Group, Department of GU Medicine, Leeds General Infirmary, Leeds, UK
  1. Correspondence to:
 Ian Simms
 National Chlamydia Screening Programme, HIV & STI Department, Health Protection Agency Centre for Infections, London, UK; ian.simms{at}hpa.org.uk

https://doi.org/10.1136/sti.2007.025213

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In the government White Paper, Choosing Health the National Chlamydia Screening Programme (NCSP) is described as ‘the cornerstone of the drive for better sexual health’.1 The NCSP is delivered through interventions, which aim to control and prevent chlamydia, the most common bacterial sexually transmitted infection (STI) seen in England, through early detection and treatment of asymptomatic infection. This flexible approach includes one-to-one interviewing and innovative methods of opportunistic recruitment such as email access to postal kits in people <25 years of age.

    Chlamydia infection rates …

    View Full Text

    Footnotes

    • Competing interests: none declared